홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

4-Piperidinecarboxamide → 1-(3-Methoxyphenyl)piperidine-4-carboxamide

HRID 297
노트
인쇄 미리보기

반응식

HRID 297 반응식
COc1cccc(Br)c1.NC(=O)C1CCNCC1>CC(=O)O.CC(=O)O.CC(C)CN1CCN2CCN(CC(C)C)P1N(CC(C)C)CC2.C[Si](C)(C)[N-][Si](C)(C)C.Cc1ccccc1.[Li+].[Pd]>COc1cccc(N2CCC(C(N)=O)CC2)c1
참가 물질반응 조건실험 절차출처 및 근거반응 노트

참가 물질

7

반응물 2

HCID 37724-PiperidinecarboxamideHCID 169713-Bromoanisole

생성물 1

HCID 106097471-(3-Methoxyphenyl)piperidine-4-carboxamide수율 0%

시약·촉매·용매 4

HCID 2733832Lithium hexamethyldisilazane시약HCID 4144353Palladium (II) acetate촉매HCID 45712432,8,9-Triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo(3.3.3)undecane촉매HCID 1140Toluene용매

반응 조건

온도
100 °C

실험 절차

piperidine-4-carboxamide (0.411 g, 3.21 mmol); 1-bromo-3-methoxybenzene (0.339 mL, 2.67 mmol) and diacetoxypalladium (0.120 g, 0.53 mmol) were thoroughly placed under an inert atmoshere. To this was added 2,8,9-triisobutyl-2,5,8,9-tetraaza-1-phosphabicyclo[3.3.3]undecane (0.037 g, 0.11 mmol); LITHIUM BIS(TRIMETHYLSILYL)AMIDE (6.15 mL, 6.15 mmol) and toluene (10 mL). The resultant mixture was stirred at 100 °C overnight. No sign of reaction by LCMS overnight. Abandoned

출처 및 근거

ORD 기록
ord-c91f5415f0604adda8f4b73dd97ab0f8
출처 데이터셋
750 AstraZeneca ELN dataset
원본 링크
출처 보기

반응 노트

불러오는 중…

이 페이지에서참가 물질반응 조건실험 절차출처 및 근거반응 노트